Lactulose for prevention of cardiovascular events after myocardial infarction: A retrospective cohort study
In this retrospective analysis, lactulose supplementation was associated with reduced in-hospital cardiovascular events following AMI. However, these preliminary findings require validation in larger prospective studies to establish causality and elucidate underlying gut-mediated mechanisms. If confirmed, lactulose may represent a simple and accessible adjunct therapy in post-infarction care.
Authors
- Lin Chen (ORCID: https://orcid.org/0000-0001-8639-655X)
- Fei Wang (ORCID: https://orcid.org/0000-0003-3762-4290)
- Sheng Qin (ORCID: https://orcid.org/0000-0001-9530-2017)
- Ming Sui
- Tomoaki Ishigami
- Hui Zhang (ORCID: https://orcid.org/0009-0007-5278-6358)
Institutions
- Fujian Medical University (CN)
- Second Affiliated Hospital of Fujian Medical University (CN)
- Nanjing Medical University (CN)
- Yokohama City University (JP)
Publication Details
- Journal
- JRSM Cardiovascular Disease
- Published
- 2025-04-01
- DOI
- https://doi.org/10.1177/20480040251393767
- Primary Topic
- Gut microbiota and health
- Type
- article
- Field-Weighted Citation Impact
- 0.00